OraSure Technologies, Inc. (OSUR) Q1 2026 Earnings Call Transcript
OraSure Announces First Quarter 2026 Financial Results
OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th
OraSure Technologies Appoints John D. Bertrand to its Board of Directors
OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above Two Hundred Day Moving Average – Here’s Why
OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above 200-Day Moving Average – Here’s What Happened
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital
Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance
Exclusive: Altai Capital presses OraSure to sell and give it board seats, letter says
OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript
Agape ATP (NASDAQ:ATPC) vs. OraSure Technologies (NASDAQ:OSUR) Head to Head Survey
OraSure to Launch OraQuick™ HIV Self-Test in Canada
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital
Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device
OraSure Technologies Issues Statement Regarding Altai Capital's Intent to Nominate Director Candidates
Altai Capital Management Announces Intention to Nominate Two Highly-Qualified Candidates for Election to OraSure Board of Directors
OraSure Technologies, Inc. (OSUR) Q3 2025 Earnings Call Transcript
OraSure Technologies (OSUR) Reports Q3 Loss, Lags Revenue Estimates
OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th
OraSure Technologies Appoints Steven K. Boyd to its Board of Directors
Exclusive: Altai Capital lays groundwork for board fight at OraSure Technologies, sources say
Exclusive: Healthcare entrepreneur's letter threatens 'adversarial path' after OraSure Tech rebuffs bid
OraSure (OSUR) Q2 Revenue Falls 43%
OraSure Technologies, Inc. (OSUR) Q2 2025 Earnings Call Transcript
OraSure Technologies (OSUR) Reports Q2 Loss, Beats Revenue Estimates
OraSure Appoints Anne Messing as Chief Commercial Officer
OraSure Technologies: An Asymmetric Bet
OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th
OraSure Technologies received takeover bid from industry entrepreneur, sources say
OraSure Launches Novel Blood Collection Device for Proteomic Research
Orasure Technologies: Multiple Shots To Deliver Value
OraSure Technologies, Inc. (OSUR) Q1 2025 Earnings Call Transcript
OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue Estimates
OraSure Technologies: Historically Cheap
OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th
OraSure Announces $40 Million Stock Repurchase Program
OraSure Technologies, Inc. (OSUR) Q4 2024 Earnings Call Transcript
OraSure Technologies (OSUR) Reports Q4 Loss, Tops Revenue Estimates
OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th
OraSure (OSUR) Upgraded to Strong Buy: What Does It Mean for the Stock?
New Strong Buy Stocks for January 27th
Should Value Investors Buy OraSure Technologies (OSUR) Stock?
New Strong Buy Stocks for January 16th
OraSure to Present at the J.P Morgan Healthcare Conference
Are Investors Undervaluing OraSure Technologies (OSUR) Right Now?
CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents
OraQuick® HIV Self-Test Now Approved for Use in Adolescents
OSUR Stock Rises Following the Acquisition of Sherlock Biosciences